Hepatitis C therapy before and after liver transplantation

被引：45

作者：

Terrault, Norah A. ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA

来源：

LIVER TRANSPLANTATION | 2008年 / 14卷 / 10期

关键词：

D O I：

10.1002/lt.21624

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：S58 / S66

页数：9

共 41 条

[1] High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence:: possible de novo autoimmune hepatitis? [J].

Berardi, S. ;

Lodato, F. ;

Gramenzi, A. ;

D'Errico, A. ;

Lenzi, M. ;

Bontadini, A. ;

Morelli, M. C. ;

Tame, M. R. ;

Piscaglia, F. ;

Biselli, M. ;

Sama, C. ;

Mazzella, G. ;

Pinna, A. D. ;

Grazi, G. ;

Bernardi, M. ;

Andreone, P. .

GUT, 2007, 56 (02) :237-242

[2] Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation [J].

Berenguer, M. ;

Palau, A. ;

Aguilera, V. ;

Rayon, J. -M. ;

Juan, F. S. ;

Prieto, M. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (03) :679-687

[3] Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin [J].

Berenguer, Marina .

JOURNAL OF HEPATOLOGY, 2008, 49 (02) :274-287

[4]

Bzowej NH, 2006, HEPATOLOGY, V44, p188A

[5] Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation [J].

Castells, L ;

Vargas, V ;

Allende, H ;

Bilbao, I ;

Lázaro, JL ;

Margarit, C ;

Esteban, R ;

Guardia, J .

JOURNAL OF HEPATOLOGY, 2005, 43 (01) :53-59

[6]

Castells L, 2006, ANTIVIR THER, V11, P1061

[7] Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials [J].

Chalasani, N ;

Manzarbeitia, C ;

Ferenci, P ;

Vogel, W ;

Fontana, RJ ;

Voigt, M ;

Riely, C ;

Martin, P ;

Teperman, L ;

Jiao, J ;

Lopez-Talavera, JC .

HEPATOLOGY, 2005, 41 (02) :289-298

[8] Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus [J].

Cholongitas, E ;

Samonakis, D ;

Patch, D ;

Senzolo, M ;

Burroughs, AK ;

Quaglia, A ;

Dhillon, A .

TRANSPLANTATION, 2006, 81 (03) :488-490

[9] A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation [J].

Crippin, JS ;

McCashland, T ;

Terrault, N ;

Sheiner, P ;

Charlton, MR .

LIVER TRANSPLANTATION, 2002, 8 (04) :350-355

[10] A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients [J].

Davis, GL ;

Nelson, DR ;

Terrault, N ;

Pruett, TL ;

Schiano, TD ;

Fletcher, CV ;

Sapan, CV ;

Riser, LN ;

Li, YF ;

Whitley, RJ ;

Gnann, JW .

LIVER TRANSPLANTATION, 2005, 11 (08) :941-949

← 1 2 3 4 5 →